Table 1

Latencies of primary and secondary leukemias

Leukemic cellsLatency of primary AML, dLatency of secondary AMLLatency of secondary AML after culture
cME3a 80 21.4 ± 0.6 (n = 5) ND 
ME4a 76 26.2 ± 1.1 (n = 5) 17.8 ± 9.2 (n = 5)* 
ME4b 83 26.8 ± 0.5 (n = 5) ND 
ME4c 75 22.4 ± 2.5 (n = 5) ND 
ME5a 83 16.6 ± 2.2 (n = 10) 22.0 ± 9.5 (n = 10)* 
ME7a 81 34.2 ± 3.3 (n = 5) 14.2 ± 3.3 (n = 5)* 
ME7b 89 30.5 ± 2.4 (n = 4) ND 
ME7c 83 37.0 ± 7.4 (n = 5) ND 
Leukemic cellsLatency of primary AML, dLatency of secondary AMLLatency of secondary AML after culture
cME3a 80 21.4 ± 0.6 (n = 5) ND 
ME4a 76 26.2 ± 1.1 (n = 5) 17.8 ± 9.2 (n = 5)* 
ME4b 83 26.8 ± 0.5 (n = 5) ND 
ME4c 75 22.4 ± 2.5 (n = 5) ND 
ME5a 83 16.6 ± 2.2 (n = 10) 22.0 ± 9.5 (n = 10)* 
ME7a 81 34.2 ± 3.3 (n = 5) 14.2 ± 3.3 (n = 5)* 
ME7b 89 30.5 ± 2.4 (n = 4) ND 
ME7c 83 37.0 ± 7.4 (n = 5) ND 

Values represent the latency of the primary leukemias and the mean latency and SD (numbers of mice per group are indicated) of secondary leukemias resulting from transplantation of the primary leukemias ex vivo or after culture for 1 month in vitro.

ND indicates not determined.

*

In vitro culture of leukemic cells caused a small but significant increase in ME5a latency (P = .038, Mantel-Haenszel log-rank test), had no effect on ME4a latency (P = .269), and reduced the latency of ME7a (P = .002).

or Create an Account

Close Modal
Close Modal